| |
| |
| Guiding Your Product to Success:
Maximize Outcomes with OptiDose Design Solution |
|
|
| Achieving development milestones is critical to progressing your molecule to the clinic, but this doesn’t always translate to successful medicines or better outcomes for patients and stakeholders.
OptiDose Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. |
|
|
| Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders. |
|
|
| |
| The Right Technologies to Address
Patient Needs, Reliably Supplied |
|
|
| Catalent’s comprehensive approach to drug development coupled with the broadest selection of advanced drug delivery technologies and manufacturing platforms, enables us to match stakeholder considerations with the right solutions. |
|
|
| Additionally, our expertise in potent handling allows us to address patient needs and challenges across a wide range of therapeutic areas, including oncology and rare disease. We can effectively address issues such as dose loading, taste masking, drug release, food effects, and more. |
|
|
| |
| On-Demand Webinar: A Stagewise Approach to
High Potency Drug Product Clinical Development
& Commercialization |
|
|
| From patients’ perspectives, oral dosage forms are also the preferred choice because of their familiarity and ease of self-administration. In this webinar, participants will both hear a panel of industry experts discuss practical challenges in oral drug development and gain valuable insights into current approaches to overcoming challenges in developing oral dosage forms that are more patient friendly. |
|
|
| |
| Meet Catalent at Upcoming Events to Learn More About Our Advanced Drug Delivery Technologies |
|
|
| As a global leader in drug delivery solutions we have the deepest expertise, the broadest offerings, and the most innovative technologies to improve the performance of your products from discovery to market and beyond. Connect with the Catalent team at one of our upcoming events to learn more.
Controlled & Modified Drug Release Summit | Princeton, New Jersey | May 16-17, 2023 Hear Catalent’s Karu Sukuru, R.Ph., Ph.D, Global Vice President, Rx Product Development, present on advances in softgel technology and gain insight into how softgel offers formulators versatility in designing patient-centric drug products. |
|
|
| |
| |
| |
| |
| Every molecule has a challenge. We have a solution. |
|
|
| |
| or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
